Jennifer Witcher

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Pharmacokinetics and Pharmacodynamics of Edivoxetine (LY2216684), a Norepinephrine Reuptake Inhibitor, in Pediatric Patients with Attention-Deficit/ Hyperactivity Disorder

Atomoxetine improves sleepiness and global severity of illness but not the respiratory disturbance index in mild to moderate obstructive sleep apnea with sleepiness

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

Comparative Metabolic Capabilities and Inhibitory Profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17

Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac

Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks

Impulsivity, Compulsivity, and Top-Down Cognitive Control

Psychedelics

Common and Unique Therapeutic Mechanisms of Stimulant and Nonstimulant Treatments for Attention-Deficit/Hyperactivity Disorder

NEW SYNTHESIS OF L-FMAU FROM L-ARABINOSE

A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorder

Psychiatric Pharmacogenomics in Pediatric Psychopharmacology

A Practical Synthesis of L-FMAU from L-Arabinose

The role of the posterior cingulate cortex in cognition and disease

Microfluidic organs-on-chips

Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents

Atomoxetine Modulates Right Inferior Frontal Activation During Inhibitory Control: A Pharmacological Functional Magnetic Resonance Imaging Study

Norepinephrine and acetylcholine mediation of the components of reflexive attention: implications for attention deficit disorders

Identification of 1S,2R-milnacipran analogs as potent norepinephrine and serotonin transporter inhibitors

Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades

DNA Microarray Technology in the Clinical Environment:The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping

The Attention System of the Human Brain: 20 Years After

Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design

Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?

Metabolism-guided drug design

Pathophysiology of Sleep Apnea

P450-catalyzed asymmetric cyclopropanation of electron-deficient olefins under aerobic conditions

NADPH-Dependent Covalent Binding of [³H]Paroxetine to Human Liver Microsomes and S-9 Fractions: Identification of an Electrophilic Quinone Metabolite of Paroxetine

Drug Resistance in Cancer: An Overview

Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States

Atomoxetine Pharmacokinetics in Children and Adolescents with Attention Deficit Hyperactivity Disorder

CYP2D6 and Clinical Response to Atomoxetine in Children and Adolescents With ADHD

An Open-Label, Dose-Ranging Study of Atomoxetine in Children with Attention Deficit Hyperactivity Disorder

Clinical Pharmacokinetics of Atomoxetine

Effect of Potent CYP2D6 Inhibition by Paroxetine on Atomoxetine Pharmacokinetics

Disposition and Metabolic Fate of Atomoxetine Hydrochloride: The Role of CYP2D6 in Human Disposition and Metabolism

Poster #220 A PHASE 1B STUDY INVESTIGATING THE POTENTIAL INTERACTION BETWEEN LY2140023 AND SECOND GENERATIONANTIPSYCHOTICS IN SUBJECTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER

Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil in woodchucks

Treatment of Presumed Fungal Endophthalmitis With Oral Fluconazole

Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites